Identification of cognitively impaired patients at risk for development of Alzheimer’s disease dementia: an analysis of US Medicare claims data-Reference-Cited by-同舟云学术

Identification of cognitively impaired patients at risk for development of Alzheimer’s disease dementia: an analysis of US Medicare claims data

Published:2022-03-16 Issue:5 Volume:22 Page:773-786
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Potashman Michele¹,Parcher Benjamin¹,Zhou Jia¹,Hou Qiang¹,Stefanacci Richard²

Affiliation:

1. Biogen, Cambridge, MA, USA

2. Jefferson College of Population Health, Thomas Jefferson University, Philadelphia, PA, USA

Funder

Biogen

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2022.2045956

Reference40 articles.

1. Alzheimer’s Disease International. World Alzheimer report 2018: the state of the art of dementia research: new frontiers [Internet]. London: Alzheimer’s Disease International. Available from:https://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf. Accessed. 2021 November5.

2. 2021 Alzheimer's disease facts and figures

3. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

4. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

5. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Economic Assessment in Early-Stage Dementia by Severity and Amyloid-β Status: A 5-Year Retrospective Claims Study of GERAS-US Patients;Journal of Alzheimer's Disease;2023-01-17